Top

European Archives of Oto-Rhino-Laryngology

Published in:

01-07-2021 | Smelling Disorder | Review Article

Anosmia: an evolution of our understanding of its importance in COVID-19 and what questions remain to be answered

Authors: Sven Saussez, Jerome R. Lechien, Claire Hopkins

Published in: European Archives of Oto-Rhino-Laryngology | Issue 7/2021

Abstract

Background

From the start of the pandemic, many European otolaryngologists observed an unprecendented number of anosmic patients. Early reports proposed that anosmia could be the first or even the only symptom of COVID-19 infection, prompting calls for self-isolation in affected patients.

Methods

In the present article, we review the COVID-19 anosmia literature and try to answer the following two questions: first, why is COVID-19 infection responsible for such a high incidence of anosmia? Second, in patients with more severe forms is anosmia really less prevalent and why?

Results

In terms of the etiology of olfactory dysfunction, several hypotheses were proposed at the outset of the pandemic; that olfactory cleft inflammation and obstruction caused a localized conductive loss, that there was injury to the sustentacular supporting cells in the olfactory epithelium or, given the known neurotropic potential of coronavirus, that the virus could invade and damage the olfactory bulb. Olfactory cleft obstruction may contribute to the olfactory dysfunction in some patients, perhaps most likely in those that show very early resolution, it cannot account for the loss in all patients.

Moreover, disordered regrowth and a predominance of immature neurons have been shown to be associated with parosmia, which is a common finding amongst patients with Covid-related anosmia. A central mechanism therefore certainly seems to be consistent with the group of patients with more prolonged olfactory deficits. Sustentacular cells showing ACE-2 immunohistochemical expression 200 to 700 times greater than nasal or tracheal epithelia seem to be the main SARS-CoV-2 gateway.

As the pathophysiology of COVID-19 anosmia seems to be better understood, the question of why patients with a moderate to severe form of COVID-19 infection have less olfactory involvement remains unresolved. Different potential explanations are discussed in this review.

Conclusions

The last 5 months have benefited from great international collaborative research, first highlighting and then proving the value of loss of smell and taste as a symptom of COVID-19. Adoption of loss of smell into the case definition by international public health bodies will facilitate control of disease transmission.

Hopkins C. Loss of sense of smell as marker of COVID-19 infection https://www.entuk.org/sites/default/files/files/Loss%2520of%2520sense%2520of%2520smell%2520as%2520marker%2520of%2520COVID.pd. Accessed Mar 2020

Lechien JR, Chiesa-Estomba CM, De Siati DR, Horoi M, Le Bon SD, Rodriguez A, Dequanter D, Blecic S, El Afia F, Distinguin L, Chekkoury-Idrissi Y, Hans S, Delgado IL, Calvo-Henriquez C, Lavigne P, Falanga C, Barillari MR, Cammaroto G, Khalife M, Leich P, Souchay C, Rossi C, Journe F, Hsieh J, Edjlali M, Carlier R, Ris L, Lovato A, De Filippis C, Coppee F, Fakhry N, Ayad T, Saussez S (2020) Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): a multicenter European study. Eur Arch Otorhinolaryngol 6:1–11. https://doi.org/10.1007/s00405-020-05965-1CrossRef

Lechien JR, Chiesa-Estomba CM, Hans S, Barillari MR, Jouffe L, Saussez S (2020) Loss of smell and taste in 2013 European patients with mild to moderate COVID-19. Ann Intern Med. https://doi.org/10.7326/M20-2428CrossRefPubMedPubMedCentral

Lechien JR, Cabaraux P, Chiesa-Estomba CM, Khalife M, Plzak J, Hans S, Martiny D, Calvo-Henriquez C, Barillari MR, Hopkins C, Saussez S (2020) Psychophysical olfactory tests and detection of COVID-19 in patients with sudden onset olfactory dysfunction: a prospective study. Ear Nose Throat J 29:145561320929169. https://doi.org/10.1177/0145561320929169CrossRef

Lechien JR, Cabaraux P, Chiesa-Estomba CM, Khalife M, Hans S, Calvo-Henriquez C, Martiny D, Journe F, Sowerby L, Saussez S (2020) Objective olfactory evaluation of self-reported loss of smell in a case series of 86 COVID-19 patients. Head Neck. https://doi.org/10.1002/hed.26279CrossRefPubMedPubMedCentral

Romero-Sánchez CM, Díaz-Maroto I, Fernández-Díaz E et al (2020) Neurologic manifestations in hospitalized patients with COVID-19: the ALBACOVID registry. Neurology. https://doi.org/10.1212/WNL.0000000000009937CrossRefPubMed

Moein ST, Hashemian SMR, Mansourafshar B, Khorram-Tousi A, Tabarsi P, Doty RL (2020) Smell dysfunction: a biomarker for COVID-19. Int Forum Allergy Rhinol. 10(8):944–950. https://doi.org/10.1002/alr.22587CrossRefPubMed

Hornuss D, Lange B, Schroter N, Rieg S, Kern WV, Wagner D (2020) Anosmia in COVID-19 patients. Clin Microbiol Infect. S1198-743X(20):30294–30299. https://doi.org/10.1016/j.cmi.2020.05.017CrossRef

Vaira LA, Hopkins C, Salzano G, Petrocelli M, Melis A, Cucurullo M et al (2020) Olfactory and gustatory function impairment in COVID-19 patients: Italian objective multicenter-study. Head Neck 42(7):1560–1569CrossRef

10.

Hopkins C, Surda P, Whithead E, Kumar BN (2020) Early recovery following new onset anosmia during the COVID-19 pandemic: an observational cohort study. J Otolaryngol Head Neck Surg 49(1):26. https://doi.org/10.1186/s40463-020-00423-8CrossRefPubMedPubMedCentral

11.

Vaira L, Hopkins C, Petrocelli M, Lechien J, Chiesa-Estomaba C et al (2020) Smell and taste recovery in COVID-19 patients: A 60 day objective and prospective study. J Laryngol Otol. https://doi.org/10.1017/S0022215120001826CrossRefPubMedPubMedCentral

12.

Chen M, Shen W, Rowan N et al (2020) Elevated ACE2 expression in the olfactory neuroepithelium: implications for anosmia and upper respiratory SARS-COV-2 entry and replication. BioRxiv. https://doi.org/10.1101/2020.05.08.084996CrossRefPubMedPubMedCentral

13.

Lambert DW, Yarski M, Warner FJ, Thornhill P, Parkin ET, Smith AI et al (2005) Tumor necrosis factor-alpha convertase (ADAM17) mediates regulated ectodomain shedding of the severe-acute respiratory syndrome-coronavirus (SARS-CoV) receptor, angiotensin-converting enzyme-2 (ACE2). J Biol Chem 280(34):30113–30119CrossRef

14.

Jia HP, Look DC, Tan P, Shi L, Hickey M, Gakhar L et al (2009) Ectodomain shedding of angiotensin converting enzyme 2 in human airway epithelia. Am J Physiol Lung Cell Mol Physiol 297(1):L84–96CrossRef

15.

Gelardi M, Notargiacomo M, Trecca EMC, Cassano M, Ciprandi G (2020) COVID-19 and nasal cytobrush cytology. Acta Cytol 64(4):397–398CrossRef

16.

Suzuki M, Saito K, Min WP, Vladau C, Toida K, Itoh H, Murakami S (2007) Identification of viruses in patients with postviral olfactory dysfunction. Laryngoscope 117(2):272–277CrossRef

17.

Netland J, Meyerholz DK, Moore S, Cassell M, Perlman S (2008) Severe acute respiratory syndrome coronavirus infection causes neuronal death in the absence of encephalitis in mice transgenic for human ACE2. J Virol 82(15):7264–7275. https://doi.org/10.1128/JVI.00737-08CrossRefPubMedPubMedCentral

18.

Bulfamante G, Chiumello D, Canevini MP et al (2020) First ultrastructural autoptic findings of SARS-Cov-2 in olfactory pathways and brainstem. Min Anestesiol. 86(6):678–679. https://doi.org/10.23736/S0375-9393.20.14772-2CrossRef

19.

Meinhardt J, Radke J, Dittmayer C et al. Olfactory Transmucosal SARS-Cov-2 Invasion as Port Of Central Nervous System Entry In COVID-19 Patients. 2020; bioRxiv preprint. https://www.biorxiv.org/content/10.1101/2020.06.04.135012v1

20.

Laurendon T, Radulesco MJ et al (2020) Bilateral transient olfactory bulbs edema during COVID-19-related anosmia. Neurology. https://doi.org/10.1212/WNL.0000000000009850CrossRefPubMed

21.

Politi LS, Salsano E, Grimaldi M (2020) Magnetic resonance imaging alteration of the brain in a patient with coronavirus disease 2019 (COVID-19) and anosmia. JAMA Neurol. https://doi.org/10.1001/jamaneurol.2020.2125(Published online May 29, 2020)CrossRefPubMed

22.

Graziadei PPC, Karlan MS, Monti Graziadei GA, Bernstein JJ (1980) Neurogenesis of sensory neurons in the primate olfactory system after section of the fila olfactoria. Brain Res 186:289–300CrossRef

23.

Schwob JE (2002) Neural regeneration and the peripheral olfactory system. Anat Rec 269(1):33–49CrossRef

24.

Tian J, Pinto JM, Xin Y et al (2015) Dexamethasone affects mouse olfactory mucosa gene expression and attenuates genes related to neurite outgrowth. Int Forum Allergy Rhinol 5(10):907–918. https://doi.org/10.1002/alr.21586Epub 2015 Jul 3CrossRefPubMed

25.

Leopold DA, Loehrl TA, Schwob JE (2002) Long-term follow-up of surgically treated phantosmia. Arch Otolaryngol Head Neck Surg 128642:647

26.

Chung TW, Sridhar TW, Zhang AJ (2020) Olfactory dysfunction in coronavirus disease 2019 patients: observational cohort study and systematic review. Open Forum Infect Dis 7(6):ofaa199CrossRef

27.

Yan CH, Faraji F, Prajapati DP et al (2020) Self-reported olfactory loss associates with outpatient clinical course in COVID-19. Int Forum Allergy Rhinol. https://doi.org/10.1002/alr.22592CrossRefPubMedPubMedCentral

28.

Ship JA, Pearson JD, Cruise LJ, Brant LJ, Metter EJ (1996) Longitudinal changes in smell identification. Journal of gerontology series A. Biol Sci Med Sci 51:86–91

29.

Breckenridge LJ, Cameron J, Puri N et al (1997) Localised degeneration occurs in aged mouse olfactory epithelium. J Anat 191:151–154. https://doi.org/10.1046/j.1469-7580.1997.19110151CrossRefPubMedPubMedCentral

30.

Bunyavanich S, Do A, Vicencio A (2020) Nasal gene expression of angiotensin-converting enzyme 2 in children and adults. JAMA 323(23):2427–2429. https://doi.org/10.1001/jama.2020.8707CrossRefPubMedPubMedCentral

31.

van Riel D, Verdijk R, Kuiken T (2015) The olfactory nerve: a shortcut for influenza and other viral diseases into the central nervous system. J Pathol 235(2):277–287CrossRef

Title: Anosmia: an evolution of our understanding of its importance in COVID-19 and what questions remain to be answered
Authors: Sven Saussez
Jerome R. Lechien
Claire Hopkins
Publication date: 01-07-2021
Publisher: Springer Berlin Heidelberg
Keywords: Smelling Disorder
Coronavirus
Smelling Disorder
COVID-19
Anosmia
Published in: European Archives of Oto-Rhino-Laryngology / Issue 7/2021
Print ISSN: 0937-4477
Electronic ISSN: 1434-4726
DOI: https://doi.org/10.1007/s00405-020-06285-0

At a glance: The STEP trials

Springer Medicine

Anosmia: an evolution of our understanding of its importance in COVID-19 and what questions remain to be answered

Abstract

Background

Methods

Results

Conclusions

At a glance: The STEP trials

Springer Medicine

Abstract

Background

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 7/2021

A novel technique for patulous Eustachian tube augmentation

3D endoscopy shows enhanced anatomical details and depth perception vs 2D: a multicentre study

Evaluation of the relationship between patient expectation, patient expectation coverage rates and patient satisfaction in open primary septorhinoplasty surgery: a prospective randomized study

Binaural hearing restoration with a bilateral fully implantable middle ear implant

Clinical significance of smell and taste dysfunction and other related factors in COVID-19

The role of adjuvant systemic steroids in the management of periorbital cellulitis secondary to sinusitis: a systematic review and meta-analysis